BioImagene Launches AgilityBio, a New Generation Contract Research Organization Leveraging Its Innovative Digital Pathology System
CUPERTINO, Calif.–(BUSINESS WIRE)–BioImagene, a leading provider of innovative digital pathology solutions for preclinical research and cancer diagnosis, launched AgilityBio — an integrated contract research organization (CRO). AgilityBio offers preclinical and clinical services in partnership with well established Indian CROs. It provides its clients with a US-based customer liaison team to facilitate management of international projects.
Nagesh Mhatre, PhD, Halo Fund, commented, “AgilityBio brings out higher efficiency and high quality solutions for research and clinical pathology. The critical information sharing among pathologists at a rapid speed is an invaluable contribution.”
Anula Jayasuria, MD., PhD, Managing Director, Evolvence India Life Sciences Fund, commented, “I am very confident that AgilityBio will make a significant impact in the outsourcing marketplace. AgilityBio’s competitive advantage is bridging the distance between US customers and Indian service providers.”
AgilityBio’s integrated service offerings include preclinical services, Phase I – IV clinical and diagnostic trials and biomarker discovery for the pharmaceutical and biotech industries. It has the advantage of using BioImagene’s web-based digital pathology technology, to provide access to image data anywhere, any time.
Mohan Uttarwar, CEO, BioImagene, said, "AgilityBio will bring about a synergy between cutting-edge digital pathology technologies and India’s vibrant pharmaceutical and CRO industry eager to work with state of the art R&D methods. Using high throughput techniques is not just an incremental improvement, but a major step towards easing bottlenecks and reducing time to market for drugs. We are confident that the AgilityBio team of experienced professionals will contribute to accelerating the global drug development process."
Roli Khattri, PhD, Chief Scientific Officer, AgilityBio, explained, "AgilityBio is an integrated CRO. We are technology driven with the capability to deliver high quality services on a global stage. Our goal is to help our customers achieve their R&D goals with increased efficiency using innovative technology solutions."
AgilityBio, an affiliate of BioImagene, provides the next generation of integrated outsourcing solutions for pharmaceutical and biotech companies. AgilityBio facilitates outsourcing of preclinical studies, therapeutic and diagnostic clinical trials and biomarker studies.
BioImagene is a leading provider of total digital pathology solutions for applications including clinical diagnostics and drug discovery. BioImagene products are FDA cleared for specific clinical applications, and are intended for research use for other applications.